What Is MOTS-c?
MOTS-c (Mitochondrial Open reading frame of the twelve S rRNA-c) is a mitochondria-derived peptide — a short peptide encoded within the mitochondrial genome itself rather than the nuclear genome. Discovered in 2015 by researchers at the University of Southern California, MOTS-c represented a paradigm shift in understanding mitochondrial biology: mitochondria, long thought to primarily produce energy, were revealed to also produce bioactive peptides that act as metabolic hormones. With 210 monthly searches in Australia and rapidly growing international research interest, MOTS-c is one of the most scientifically significant emerging research compounds in longevity and metabolic biology.
MOTS-c consists of 16 amino acids and is encoded within the 12S rRNA gene of the mitochondrial genome. Its identification opened a new field of mitochondria-derived peptide (MDP) research, with MOTS-c joining other mitochondria-derived peptides including humanin and SHLP1-6 as subjects of intense investigation for their roles in metabolic regulation and ageing biology.
MOTS-c and Metabolic Regulation
The primary research application of MOTS-c centres on its role in metabolic adaptation. Research has shown MOTS-c acting as a mitochondrial stress signal, released when mitochondria experience metabolic stress (particularly glucose shortage), and travelling to the nucleus where it regulates gene expression to promote metabolic adaptation. This nucleus-targeting action — unusual for a mitochondria-derived molecule — allows MOTS-c to coordinate cellular metabolism at the genomic level in response to mitochondrial status.
Metabolic effects documented in research include improved insulin sensitivity, enhanced glucose uptake in skeletal muscle, increased fatty acid oxidation, and activation of the AMPK pathway — a key cellular energy sensor that promotes energy-efficient metabolic states. These metabolic effects have made MOTS-c relevant to research in type 2 diabetes models, obesity biology, and metabolic syndrome research.
MOTS-c and Exercise Biology
One of the most intriguing aspects of MOTS-c research is its relationship to exercise. Plasma MOTS-c levels rise during physical exercise and remain elevated in physically active individuals, leading researchers to propose MOTS-c as an 'exercise factor' — a molecule that mediates some of the metabolic benefits of physical activity. This hypothesis has been tested by administering exogenous MOTS-c to sedentary animals, which produced metabolic improvements resembling those seen with exercise training.
In aged animal models, MOTS-c administration has reversed some age-related metabolic dysfunction, improving physical performance metrics and insulin sensitivity in ways that recapitulate the benefits seen in younger animals. These exercise-mimetic properties have generated substantial longevity research interest, with researchers exploring whether MOTS-c can help maintain metabolic health in ageing populations. Optic Labs supplies MOTS-c in 10mg and 40mg formats alongside SS-31 and NAD+ for researchers studying the full mitochondrial health landscape.
MOTS-c and Ageing
Natural MOTS-c levels decline with age, paralleling the well-documented age-related decline in mitochondrial function and metabolic flexibility. This age-related decline in a metabolic hormone that promotes glucose metabolism, insulin sensitivity, and mitochondrial adaptation is consistent with the broader pattern of metabolic dysfunction seen in ageing biology. Research has explored whether MOTS-c supplementation can restore more youthful metabolic function in aged models.
Frequently Asked Questions
Where does MOTS-c come from?
MOTS-c is encoded within the mitochondrial genome (the 12S rRNA gene) and is produced inside mitochondria. It is then released and can travel to the nucleus where it regulates gene expression — an unusual and scientifically significant property for a mitochondria-derived molecule.
What are MOTS-c's main research applications?
Primary applications include metabolic regulation (insulin sensitivity, glucose metabolism, fatty acid oxidation), exercise biology (MOTS-c rises with exercise and may mediate exercise benefits), ageing research (age-related MOTS-c decline correlates with metabolic dysfunction), and mitochondrial health research.
How does MOTS-c differ from SS-31?
MOTS-c is a mitochondria-derived peptide that regulates metabolic gene expression and acts as a metabolic hormone, primarily affecting glucose metabolism and insulin sensitivity. SS-31 is a synthetically designed peptide that localises to mitochondrial membranes to stabilise cardiolipin and improve electron transport chain efficiency. They target mitochondrial health through completely different mechanisms.
Is MOTS-c legal in Australia?
MOTS-c is not a scheduled substance in Australia and can be purchased for research purposes. Optic Labs supplies it for research use only, not for human therapeutic application.
This article is for educational and research purposes only. Optic Labs products are intended for research use only and are not for human consumption. Always consult a qualified healthcare professional before considering any compounds.